Trials / Completed
CompletedNCT03233295
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Kwang Dong Pharmaceutical co., ltd. · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 B.O.N. Injection | cholecalciferol 200,000IU |
Timeline
- Start date
- 2014-10-23
- Primary completion
- 2016-08-27
- Completion
- 2016-08-27
- First posted
- 2017-07-28
- Last updated
- 2017-07-28
Source: ClinicalTrials.gov record NCT03233295. Inclusion in this directory is not an endorsement.